about
Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry.90Y-edotreotide for metastatic carcinoid refractory to octreotide.Hypothalamo-pituitary sarcoidosis: a multicenter study of 24 patients.Recreational Physical Activity and Differentiated Thyroid Cancer Risk: A Pooled Analysis of Two Case-Control StudiesTime course of Graves' orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancer.Thyroid effects and anticancer treatment.Management of hyperglycaemia in Cushing's disease: experts' proposals on the use of pasireotide.Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry.The value of a rapid contrast-enhanced angio-MRI protocol in the detection of head and neck paragangliomas in SDHx mutations carriers: a retrospective study on behalf of the PGL.EVA investigators.Does Molecular Genotype Provide Useful Information in the Management of Radioiodine Refractory Thyroid Cancers? Results of a Retrospective Study.Combination chemotherapy with 5-fluorouracil and dacarbazine in advanced medullary thyroid cancer, a possible alternative?Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome.Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.Thyroid tumors of uncertain malignant potential: morphologic and imunohistochemical analysis of 29 cases.Anthropometric Risk Factors for Differentiated Thyroid Cancer in Young Men and Women From Eastern France: A Case-Control Study.Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients.New-generation thyroglobulin assay: performance and implications for follow-up of differentiated thyroid carcinoma.Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience.Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women.Comparative validation of the growth hormone-releasing hormone and arginine test for the diagnosis of adult growth hormone deficiency using a growth hormone assay conforming to recent international recommendations.Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease.Malignant insulinoma: recommendations for characterisation and treatment.Molecular screening for a personalized treatment approach in advanced adrenocortical cancer.Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in young women in France: a population-based case-control study.Guidelines of the French society of endocrinology for the management of thyroid nodules.Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators.[Targeted therapies, prognostic and predictive factors in endocrine oncology].Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche Diagnostics Elecsys® Cortisol II assay.French law: what about a reasoned reimbursement of serum vitamin D assays?Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1.Is thyroid cancer recurrence risk increased after transplantation?Pegvisomant treatment in patients with acromegaly in clinical practice: The French ACROSTUDY.Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines.¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma.Neuroendocrine tumors producing calcitonin: characteristics, prognosis and potential interest of calcitonin monitoring during follow-up.18F-FLT and 18F-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours.Histopathological changes induced by selective inactivation of menin on the thyroid gland in RET÷PTC3 and E7 transgenic mice. A study of 77 cases.[Benefits and risks of iodine supplementation during pregnancy: a review of observational and experimental studies in mild-to-moderate iodine deficiency areas].Molecular analyses of thyroid tumors for diagnosis of malignancy on fine-needle aspiration biopsies and for prognosis of invasiveness on surgical specimens.An old retrocardiac mass fortuitously reclassified as paraganglioma
P50
Q33862265-52C3CD6B-260A-4C0D-9D14-0A8C1465FDFFQ34101554-58A7E974-353C-4A74-A611-B2BE95980F2EQ34323918-384D2317-5786-48C4-A8D9-B8B45AF9D549Q37104816-635252D6-51CB-41E2-B9E4-5620782CF54DQ37467757-75755CDB-45B8-4CF5-99A9-593781D5F78CQ37884705-9CEBB379-E8E1-4120-9A89-9793877D5FD0Q38066321-879B7D12-F07E-4722-A98D-98D14D9FD823Q38936796-EB98EE29-FCC5-49AE-98CB-EE95E7377C0AQ40477107-FF3EB31C-7E5A-4FC0-AB1D-835062716B70Q40629784-44C55EDA-29A2-4B8B-BDC0-A5191BD4BF62Q40757352-47B876DD-628C-450E-9540-086701D131ABQ40911655-E260DAF0-594E-4457-BF69-A2DC48E4C8D7Q41336499-4098CDF9-AA06-4D08-9B86-A5249673C3B6Q41571582-3C6FDBE5-E198-4F66-A09D-F1078B533588Q41622313-E29B18A6-5C9A-44FC-9AF2-D5FAB848B09DQ41659209-A82D536E-E6CE-4009-96E5-962AFF2CBE2DQ42464714-20FB10FB-8ECC-43C6-9CA1-67F2DC41A7F1Q42957576-25D5CAA3-5BC5-4E93-8E65-A202F4C0FFF2Q42957583-3680FEA3-667B-435D-A015-A3E935007D07Q43059511-22FEABC8-EB3E-4234-8CE8-30631E702434Q43102415-8CDF29B0-C6DE-4A49-8A23-44907561ACECQ43628313-4F27FC1E-E173-40AD-9134-A2DF44049642Q43735840-47516866-77E7-43E9-88B8-2C3A693CF9E8Q43904310-6F1077F7-59C8-45FF-A58A-FBC425F5413CQ44186312-5676AD5B-F75C-41AD-AF36-ECBAAE98EEADQ44697731-57ABF0C8-0235-44F4-AB16-051361882746Q45797561-59E371BF-95C5-4C9B-9472-9F846920E7F6Q48607879-2464A9D5-249C-4FE1-A46E-6C737D557432Q48746512-486BC001-3A4B-4731-88D8-3ADE412BF816Q49160970-03D27F87-FD76-4ED2-A4A8-BBD5F7B1FE23Q51221551-7A43508D-2995-4CF7-8643-71062B83C7A9Q51293750-C27DEC5B-DA3F-4C4D-800D-1DB31283C0A0Q51466728-50B7DDC5-1B5A-450C-91EF-A892E7656CFDQ53066863-E967C6A7-B2A4-4023-B4A7-2E21E604A5CFQ53242852-1034CF67-AE1F-48BD-A915-49D951C6BC94Q53261059-BD72549B-9F25-4BA7-93FA-C6E12C9E8572Q54195737-6C0C8F2A-ED8C-436A-9A59-7844F3A9E99AQ54374843-0AEE02E6-6364-4C6D-8450-6F4830C65E1CQ54595150-68CCCDA1-07CF-4589-9442-E79C26C8A452Q57641177-F797BD20-7CBD-426C-9970-05AA860E1551
P50
description
forsker
@nb
onderzoeker
@nl
researcher, ORCID id # 0000-0003-2515-7840
@en
name
F. Borson-Chazot
@ast
F. Borson-Chazot
@nl
Francoise Borson-Chazot
@en
Francoise Borson-Chazot
@nb
type
label
F. Borson-Chazot
@ast
F. Borson-Chazot
@nl
Francoise Borson-Chazot
@en
Francoise Borson-Chazot
@nb
altLabel
F. Borson-Chazot
@en
prefLabel
F. Borson-Chazot
@ast
F. Borson-Chazot
@nl
Francoise Borson-Chazot
@en
Francoise Borson-Chazot
@nb
P106
P31
P496
0000-0003-2515-7840